influenza
LumiraDx Gets CE Mark for Point-of-Care SARS-CoV-2, Flu Assay
The test is designed to detect and differentiate between SARS-CoV-2 and the flu, providing results within 12 minutes.
Becton Dickinson Acquires Scanwell Health to Expand Smartphone-Based At-Home Testing
BD said Scanwell will provide a digital platform that forms the basis for the development of at-home diagnostic tests for numerous infectious diseases.
Roche Plans Launch of Multiplex SARS-CoV-2, Influenza Rapid Antigen Test
The qualitative test returns results from a nasopharyngeal swab in less than 30 minutes without an instrument.
Qiagen Gets CE Mark for Molecular Multiplex Respiratory Pathogen Assay
The new QiaStat-Dx Respiratory 4 Plex molecular test can detect and differentiate between influenza A and B, RSV, and SARS-CoV-2 infections.
DiaSorin Molecular Receives CE Mark for Multiplex COVID-19, Influenza Test
The test detects and differentiates between nucleic acids from SARS-CoV-2 and influenza A/B from the same sample in one reaction well.
Apr 28, 2021